Oxford Pharmascience Group PLC (LSE:OXP) - Share price - Overview

Stock Report

Oxford Pharmascience Group PLC OXP

Last Price
GBX1.65

Day Change
0.00|0.00%

As of 26/05/2017
14:56:43 BST | GBX
Minimum 15 Minutes Delay.

Last Close1.65p
Day Range1.61 - 1.70
Mkt Cap19.89Mil
52-Wk Range1.50 - 7.32
Yield %0.00
ISINGB00B3LXPB43
Volume782,928
P/E-15.00
P/S25.00
P/CF-16.84

Share Price

Total Returns 26/05/2017

 Chg (%)  
More ...
Oxford Pharmascience Group PLC-7.04 
FTSE 100 TR GBP4.15
 
Financials
201420152016
More ...
Income Statement
Turnover0.710.750.80
Operating Profit-3.50-3.97-2.03
Net Profit-2.86-3.11-1.38
Reported EPS-0.29-0.28-0.11
Balance Sheet
Current Assets7.5624.0522.70
Non Current Assets0.050.040.03
Total Assets7.6124.0922.73
Current Liabilities0.290.310.17
Total Liabilities0.290.310.17
Total Equity7.3223.7922.56
Cash Flow
Operating Cash Flow-3.63-3.72-2.13
Net Change in Cash-3.246.353.82
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-3.08-0.20--8.09---
2018-3.27-0.22--7.60---

Company Profile

Oxford Pharmascience Group PLC is a specialty pharmaceutical company. It is engaged in the R&D and commercialization of drug products from proprietary technology platforms. It re-develops approved drugs to make them safer and easier to take.

Sector

Biotechnology

Market Position

1360 of 1851 Companies

Index

FTSE AIM All Share

Outlook

(10/03/2017) no outlook statement

Next Event 19/06/2017

Next AGM
Ratios
CompSecMkt
More ...
PER (E)-7.8915.0716.87
Div Yld (E)0.003.604.05
PEG (E)0.000.420.72
ROCE-8.42187.8415.97
Op Mrgn-255.03-6.501.61
EPS Grwth0.0056.9427.17
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanRobert Norwood
Chief Executive OfficerMarcelo Bravo
Finance Director & Company SecretaryMr. Chris Hill
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.